Neelam Sekhri

Healthcare Redesign Group

CEO

Alameda, CA

United States

SCHOLARLY PAPERS

1

DOWNLOADS

243

SSRN CITATIONS

0

CROSSREF CITATIONS

0

Scholarly Papers (1)

1.

Barriers to Access: An Assessment of Stakeholder Risks and Incentives in the Value Chain for Artemisinin Combination Therapy (ACT) Treatments

Number of pages: 15 Posted: 26 Aug 2007
Prashant Yadav, Neelam Sekhri and Kirsten Anne Curtis
Harvard Medical School, Healthcare Redesign Group and MIT-Zaragoza Logistics Program
Downloads 243 (137,808)

Abstract:

Loading...

Public Health Policy, Incentive Alignment, Artemisinin Combination Therapy, Global Health Supply Chains